# Pharmacodynamics of Nasal and Buccal Midazolam Using EEG

> **NCT01316445** · PHASE1 · TERMINATED · sponsor: **Columbia University** · enrollment: 9 (actual)

## Conditions studied

- Epilepsy

## Interventions

- **DRUG:** nasal Midazolam

## Key facts

- **NCT ID:** NCT01316445
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Funding agency no longer provide support.
- **Last updated:** 2015-02-04

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01316445

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01316445, "Pharmacodynamics of Nasal and Buccal Midazolam Using EEG". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01316445. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*